Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D

Contributed by: Business Wire

Logo

Tags

Science

Biotechnology

Research

Pharmaceutical

Oncology

Health

Genetics

Clinical Trials

Mosaic Therapeutics

More Like This

Mosaic Therapeutics to Present Poster Highlighting Preclinical Data for Lead Program MOS101 at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mestag Therapeutics Expands Leadership Team and Appoints Head of Development and General Counsel

Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer

Incyte Announces Executive Leadership Appointments

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer

Evox Therapeutics Expands Scientific Advisory Board

Ora Strengthens Global Leadership with Key Appointments in Europe and People Services